Influence of Female Sex Hormones on Ultra-Running Performance and Post-Race Recovery: Role of Testosterone.

female athletes hormonal contraception hormones muscle damage muscle fatigue physical performance ultra-endurance

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
02 10 2021
Historique:
received: 24 07 2021
revised: 21 09 2021
accepted: 28 09 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 26 10 2021
Statut: epublish

Résumé

In recent years, increasing numbers of women have participated in extremely long races. In adult males, there is a clear association between physiological levels of endogenous sex hormones and physical performance. However, the influence of plasmatic sex hormones and the effects of different types of hormonal contraception (HC) on the modulation of physical performance in adult females remain to be fully clarified. Eighteen female ultra-endurance athletes were recruited to participate in the study. Different variables were studied, including hematological parameters, body mass index, and body composition. Strength measurements were obtained using the squat-jump and hand-grip test. A repeated-measures analysis demonstrated significant differences in hematological values of CK and LDH pre-race as compared to immediately post-race and after 24/48 h. Furthermore, statistical differences were found in squat-jump and hand-grip test results after the ultramarathon. Testosterone, estradiol, and the testosterone/estrogen ratio were significantly correlated with muscle fatigue and were found to be indirect markers of muscle damage. A multivariate analysis demonstrated the protective role of testosterone against muscle damage and severe fatigue. Fluctuations in endogenous testosterone levels were correlated with greater fatigability and muscle damage after the competition. Adjusting the menstrual cycle with HC would not provide any further benefit to the athlete's competitive capacity.

Identifiants

pubmed: 34639701
pii: ijerph181910403
doi: 10.3390/ijerph181910403
pmc: PMC8508191
pii:
doi:

Substances chimiques

Biomarkers 0
Testosterone 3XMK78S47O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Sports Physiol Perform. 2018 Aug 1;13(7):926-932
pubmed: 29283683
J Sci Med Sport. 2017 Nov;20(11):965-969
pubmed: 28684053
PLoS One. 2020 Sep 11;15(9):e0238846
pubmed: 32915883
Proc Nutr Soc. 2018 Feb;77(1):32-41
pubmed: 28847313
J Strength Cond Res. 2006 Feb;20(1):103-7
pubmed: 16503668
Clin Chim Acta. 2001 Mar;305(1-2):131-9
pubmed: 11249932
Chest. 2006 Mar;129(3):551-7
pubmed: 16537851
J Appl Physiol. 1974 Aug;37(2):247-8
pubmed: 4850854
J Clin Endocrinol Metab. 2004 Feb;89(2):702-7
pubmed: 14764784
Fertil Steril. 2003 Apr;79(4):947-55
pubmed: 12749436
Int J Sports Physiol Perform. 2020 Sep 21;15(10):1377-1384
pubmed: 32957078
Sports Med. 2004;34(8):513-54
pubmed: 15248788
Sports Med. 2010 Dec 1;40(12):1037-53
pubmed: 21058750
Med Sport Sci. 2010;55:82-102
pubmed: 20956862
Endocr Rev. 2018 Oct 1;39(5):803-829
pubmed: 30010735
J Athl Train. 2019 Aug;54(8):906-914
pubmed: 31386577
J Crit Care. 2000 Mar;15(1):12-7
pubmed: 10757193
Sports Med. 1995 Apr;19(4):278-87
pubmed: 7604200
Curr Opin Clin Nutr Metab Care. 2004 May;7(3):271-7
pubmed: 15075918
Eur J Sport Sci. 2014;14(8):847-51
pubmed: 24766579
Int J Environ Res Public Health. 2021 Jan 06;18(2):
pubmed: 33418867
Int J Sports Physiol Perform. 2009 Jun;4(2):151-62
pubmed: 19567919
Knee Surg Sports Traumatol Arthrosc. 2012 Feb;20(2):361-7
pubmed: 21695466
Fertil Steril. 2002 Apr;77 Suppl 4:S34-41
pubmed: 12007900
J Clin Endocrinol Metab. 1998 Jun;83(6):1886-92
pubmed: 9626114
Br J Sports Med. 2020 May;54(10):599-604
pubmed: 31615775
J Clin Endocrinol Metab. 2004 Sep;89(9):4364-70
pubmed: 15328063
Med Sci Sports Exerc. 2020 Jun;52(6):1414-1419
pubmed: 31851041
PM R. 2020 Dec 19;:
pubmed: 33340255
J Sports Sci Med. 2019 Nov 19;18(4):615-622
pubmed: 31827345
Endocr Connect. 2020 Apr;9(4):R81-R92
pubmed: 32197237
Med Sci Sports Exerc. 2009 Jun;41(6):1241-8
pubmed: 19461542
Scand J Med Sci Sports. 2008 Dec;18(6):706-14
pubmed: 18248538
Sports Med. 2003;33(11):833-51
pubmed: 12959622
Antioxidants (Basel). 2021 Feb 27;10(3):
pubmed: 33673404
J Sci Med Sport. 2020 Aug;23(8):690-694
pubmed: 32089432
Appl Physiol Nutr Metab. 2020 Jul;45(7):707-714
pubmed: 31815525
J Strength Cond Res. 2011 Jun;25(6):1571-8
pubmed: 21399539
Int J Sports Med. 2008 Apr;29(4):277-81
pubmed: 17990209
Aust Occup Ther J. 2011 Apr;58(2):82-7
pubmed: 21418230

Auteurs

Eladio Collado-Boira (E)

Faculty of Health Sciences, Jaume I University, 12071 Castellon, Spain.

Pablo Baliño (P)

Faculty of Health Sciences, Jaume I University, 12071 Castellon, Spain.

Ana Boldo-Roda (A)

Obstetrics and Gynecology, University Hospital of La Plana, 12540 Vila-Real, Spain.

Ignacio Martínez-Navarro (I)

Department of Physical Education and Sport, University of Valencia, 46010 Valencia, Spain.
Sports Health Unit, Vithas-Nisa 9 de Octubre Hospital, 46015 Valencia, Spain.

Bárbara Hernando (B)

Faculty of Health Sciences, Jaume I University, 12071 Castellon, Spain.

Paula Recacha-Ponce (P)

Faculty of Health Sciences, Jaume I University, 12071 Castellon, Spain.

Carlos Hernando (C)

Sport Service, Jaume I University, 12071 Castellon, Spain.
Department of Education and Specific Didactics, Sport Service, Jaume I University, 12071 Castellon, Spain.

María Muriach (M)

Faculty of Health Sciences, Jaume I University, 12071 Castellon, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH